Cargando…
Mirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice
In resource-limited settings and in the military theater, fresh human whole blood is commonly transfused, but infectious risks are a concern. Sophisticated molecular testing for potential infectious agents in the whole blood is often unavailable. To address this unmet need, pathogen reduction techno...
Autores principales: | Mallavia, Beñat, Kwaan, Nicholas, Marschner, Susanne, Yonemura, Susan, Looney, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453573/ https://www.ncbi.nlm.nih.gov/pubmed/28570672 http://dx.doi.org/10.1371/journal.pone.0178725 |
Ejemplares similares
-
Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice
por: Caudrillier, Axelle, et al.
Publicado: (2015) -
Tiempo de mirasoles
por: Marmolejo Fat, Velia
Publicado: (2003) -
The National Centre for Oncological Hadrontherapy at Mirasole: hadrontherapy programme
por: Amaldi, Ugo
Publicado: (1997) -
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology
por: Yonemura, Susan, et al.
Publicado: (2021) -
Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India
por: Chatterjee, Kabita, et al.
Publicado: (2016)